Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.
暂无分享,去创建一个
M. Petzl-Erler | T. Rohan | A. Ferenczy | G. Matlashewski | L. Villa | E. Franco | E Franco | T Rohan | A Ferenczy | G Matlashewski | L Villa | M Petzl-Erler
[1] J. Bodmer,et al. Nomenclature for factors of the HLA System, 1996. , 1997, Human immunology.
[2] Andrew J. G. Simpson,et al. Low stringency-PCR (LS-PCR) allows entirely internally standardized DNA quantitation , 1995, Nucleic Acids Res..
[3] A. Reingold,et al. Genital human papillomavirus infection in female university students as determined by a PCR‐based method , 1991, JAMA.
[4] C. Brown,et al. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. , 1990, Acta cytologica.
[5] A. Štafl,et al. Cervicography: a new method for cervical cancer detection. , 1981, American journal of obstetrics and gynecology.
[6] T. Rohan,et al. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. , 1999, Journal of the National Cancer Institute.
[7] David R. Scott,et al. p53 polymorphism and risk of cervical cancer , 1998, Nature.
[8] H. Johnsen,et al. p53 polymorphism and risk of cervical cancer , 1998, Nature.
[9] E. Franco,et al. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. , 1994, Journal of the National Cancer Institute.
[10] D. Lowy,et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles , 1993, Journal of virology.
[11] David R. Scott,et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. , 1994, The Journal of infectious diseases.
[12] A. Halpern,et al. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments , 1995, Journal of virology.
[13] D. Lowy,et al. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. , 1994, Journal of the National Cancer Institute.
[14] J. Walboomers,et al. General primer‐mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas , 1990, International journal of cancer.
[15] C. Peyton,et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. , 1994, The Journal of infectious diseases.
[16] L. Mango,et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. , 1997, Revista panamericana de salud publica = Pan American journal of public health.
[17] H. Bernard,et al. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree , 1991, Journal of clinical microbiology.
[18] R. Burk,et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. , 1995, Journal of the National Cancer Institute.
[19] Diane Soloman,et al. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses: Developed and approved at the national cancer institute workshop in Bethesda, MD, December 12–13, 1988 , 1989, Diagnostic cytopathology.
[20] H. Pfister,et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups , 1993, Journal of virology.
[21] Irene M. Leigh,et al. Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer , 1998, Nature.